Shanda Asset Management Holdings LTD Medpace Holdings, Inc. Transaction History

Shanda Asset Management Holdings LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$138.87 - $214.31 $4.03 Million - $6.21 Million	-29,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$170.18 - $198.21 $2.46 Million - $2.87 Million	-14,472 Reduced 33.29%	29,000 $5.49 Million
Q1 2020 May 15, 2020	BUY	$61.71 - $101.95 $1.02 Million - $1.69 Million	16,590 Added 61.71%	43,472 $3.19 Million
Q4 2019 Feb 14, 2020	BUY	$70.08 - $84.64 $1.05 Million - $1.27 Million	15,000 Added 126.24%	26,882 $2.26 Million
Q3 2019 Nov 14, 2019	SELL	$62.38 - $85.89 $935,700 - $1.29 Million	-15,000 Reduced 55.8%	11,882 $999,000
Q1 2019 May 15, 2019	BUY	$49.38 - $70.58 $1.25 Million - $1.78 Million	25,244 Added 1541.15%	26,882 $1.59 Million
Q4 2018 Feb 14, 2019	BUY	$46.97 - $63.98 $76,936 - $104,799	1,638 New	1,638 $87,000

616

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.5B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Shanda Asset Management Holdings LTD, based on Form 13F filings with the SEC.

Stay updated on Shanda Asset Management Holdings LTD with notifications on news.